What Is Postural Orthostatic Tachycardia Syndrome?
This JAMA Patient Page describes who is typically affected by postural orthostatic tachycardia syndrome, the risk factors, and the diagnosis and treatment.
10 November 2026 – 16 November 2026 · published 16 November 2026 · Subscribe
Between 10 November 2026 and 16 November 2026 the tracker indexed 24 new peer-reviewed studies and 9 clinical-trial updates across 8 post-viral and post-infectious conditions.
Studies tracked = entries across the 8 condition feeds (each feed keeps a rolling window of recent PubMed results); trials tracked = ClinicalTrials.gov records in the current trial snapshot (last run 2026-11-16); biomarkers catalogued = marker entries across all OSMF biomarker atlases.
Full feed: POTS research tracker
This JAMA Patient Page describes who is typically affected by postural orthostatic tachycardia syndrome, the risk factors, and the diagnosis and treatment.
Postural orthostatic tachycardia syndrome (POTS) is one of the most common autonomic disorders with increasing prevalence and incidence after COVID-19 pandemic. Despite standard treatment of POTS consisting of nonpharmacologic and pharmacologic therapies that decrease heart rate and increase blood pressure and plasma volume, antidepressant medications are widely utilized in patients with POTS.
Full feed: MCAS research tracker
Allergic rhinitis (AR) is characterized by a T helper 2 (Th2)-cell-mediated immune imbalance, yet its upstream molecular drivers remain poorly defined. Interleukin-17 receptor B (IL-17Rb) has been implicated in type 2 inflammation, but its precise functional role and mechanism in AR pathogenesis are unclear.
Sulfur mustard (SM) and nitrogen mustard (NM) are potent chemical threat agents that cause severe acute- and long-term injuries. Their long-lasting skin complications include dry skin, chronic urticaria, psoriasis, and fibrosis; however, studies on these effects are limited, and a useful
Mast cells (MCs) are multifunctional immune cells with context-dependent functions in cancer. In colorectal cancer (CRC), their contribution remains debated, suggesting that distinct MC subsets may either support tumor progression or promote anti-tumor immunity.
Allergic rhinitis (AR) is an immunoglobulin E (IgE)-mediated chronic inflammatory disease. Although type 2 immune responses are central to AR, environmental exposures, epithelial barrier dysfunction, and neuroimmune interactions also contribute to disease development.
Chronic spontaneous urticaria (CSU) is a mast cell-driven inflammatory skin disorder traditionally considered self-limiting and non-life-threatening. However, accumulating evidence suggests that CSU is associated with multiple comorbidities, reflecting systemic immune and neuroinflammatory dysregulation.
Hyperbaric oxygen (HBO2) is effective against radiation cystitis. In this exploratory analysis we employed proteomics to assess biomarkers predicting clinical efficacy and the pharmacodynamics of HBO2 in radiation cystitis.
Mast Cell Activation Syndrome (MCAS) challenges conventional reductionist medical models because patients experience fluctuating symptoms across autonomic, immune, gastrointestinal, and behavioural domains, with substantial inter-individual variability and often only partial responses to organ-specific interventions. This conceptual approach reframes MCAS as a complex adaptive system in which chronic illness emerges...
Fibromyalgia is a prevalent and debilitating condition that results in generalized musculoskeletal pain, trouble sleeping, exhaustion, psychological challenges, and social problems. As a consequence of fibromyalgia's substantial therapeutic and socioeconomic burden caused by its high prevalence, uncertain etiology, wide spectrum of clinical manifestations, and sophisticated therapy, a considerable interest has...
Roseburia faecis has been reported to mitigate irritable bowel syndrome (IBS), which is characterized by altered intestinal motility, mucosal immune activation, and gut microbial dysbiosis. This study aimed to evaluate the sex-dependent effects of heat-killed R. faecis (HK-BBH024) and a viable cell-containing R. faecis preparation (L-BBH024) in a repeated water avoidance stress (rWAS)-induced IBS Wistar rat model.
The systemic and relapsing nature of urticaria cannot be fully explained by cutaneous mast-cell activation alone. Whether the gut contributes, and whether a multi-component formula such as Jingfang Mixture (JF) acts through a gut-skin route, have not been tested together at the level of microbiota, metabolites, and skin signaling together.
Food allergy (FA) pathogenesis is closely associated with perturbations of the enteric ecosystem; however, comparative studies examining how distinct allergen triggers differentially affect the enteric mycobiome (total fungal community residing in the gastrointestinal tract) and the enteric bacteriome (total bacterial community residing in the gastrointestinal tract) remain limited. Mapping these allergen-specific...
Seasonal allergic rhinitis (SAR) affects approximately 400 million individuals worldwide, yet a quantitative framework integrating the complete immunological cascade from allergen exposure to clinical symptoms is lacking. Individual pathways (Th2/IgE, TLR4/NF-κB, Th17/Treg) have been characterized in isolation, but their interactions and relative contributions to symptom generation remain poorly understood.
Localized scleroderma, or morphea, is an autoimmune fibrotic disorder characterized by dermal or deeper tissue inflammation and excessive collagen deposition, leading to skin thickening, sclerosis, and eventual atrophy. Early diagnosis is essential to prevent permanent cosmetic and functional impairment.
Superparamagnetic iron oxide nanoparticles (SPIONs) are increasingly utilised in biomedical and nanomedicine applications, raising important questions regarding early interactions with hepatic cellular systems. This study investigated how surface chemistry influences the biological behaviour of SPIONs across hepatic-relevant cell models through integrated physicochemical characterisation and response screening.
Cardiac mast cells have emerged as mechanistically versatile and clinically consequential mediators of heart failure and cardiomyopathy, acting through a diverse arsenal of preformed granule constituents,
Whey protein hydrolysate (WPH) has considerable potential as a functional food ingredient; however, its role in alleviating allergic responses and the underlying mechanisms remain insufficiently understood, particularly the potential role of gut microbiota and their metabolites. This study characterized the structural changes of WPH following enzymatic hydrolysis, evaluated its effects on allergic responses in an...
Cutaneous pain-sensing nociceptive neurons can directly recognize pathogen invasion and modulate the resulting host immune response. Neuronal recognition of
5-Fluorouracil (5-FU)-induced oral mucositis (OM) is associated with the fat-tissue-associated protein (FTO)/cytidine monophosphate kinase 2 (CMPK2)/NOD-like receptor protein 3 (NLRP3) inflammatory axis. A hamster OM model was established using 5-FU injections and mechanical irritation, with LR administered in drinking water.
Serum-specific IgE (sIgE) and skin prick testing (SPT) have limitations in diagnosing allergic rhinitis (AR). CD63, a mast cell activation biomarker reflecting degranulation extent, has unclear application in AR diagnosis.
Transfusion-related acute lung injury (TRALI) remains a serious complication of transfusion, and blood component-derived exosomes have been proposed as candidate contributors to transfusion-related inflammatory dysregulation. Rapid and practical methods to assess exosome burden in stored red blood cell (RBC) units remain limited.
No new studies this window for: Long COVID, ME/CFS, PACVS, Lyme / PTLDS, Gulf War Illness.
ClinicalTrials.gov records whose registry entry was last updated between 10 November 2026 and 16 November 2026. A registry update can be anything from a status change to an edited contact field; status shown is as of the tracker snapshot.
| NCT | Trial | Status | Phase | Agents | Updated |
|---|---|---|---|---|---|
| NCT07388550 | Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I) Long COVID | Not Yet Recruiting | Phase 1 | Keytruda | 2026-11-13 |
| NCT07930637 | Rimonabant for Cognitive Impairment in People With Post-COVID-19 Syndrome Long COVID | Not Yet Recruiting | Phase 2 | Rimonabant | 2026-11-12 |
| NCT07757555 | Guanfacine and Cromolyn Sodium for POTS: The DBPOTS Trial POTS, Other post-viral | Not Yet Recruiting | Early phase 1 | Guanfacine, Cromolyn Sodium | 2026-11-12 |
| NCT06952413 | Study of the Efficacy and Safety for Rituximab in Myalgia Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) ME/CFS | Recruiting | Phase 2 | Rituximab | 2026-11-12 |
| NCT07842302 | Fighting Fatigue in Multiple Sclerosis: TMS vs. tDCS Efficacy. Other post-viral | Enrolling By Invitation | Not applicable | Tms, Tdcs | 2026-11-10 |
| NCT07798570 | Observational Study With CICR-NAM as a Food for Special Medicinal Purposes in Post-COVID Syndrome (PCS) Long COVID | Recruiting | Not applicable | Cicr-Nam | 2026-11-10 |
| NCT07316127 | Immunoadsorption in Autoimmune Long COVID Long COVID | Recruiting | Phase 2 | Immunoadsorption | 2026-11-10 |
| NCT05350774 | Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2 Other post-viral | Enrolling By Invitation | Phase 2 | Iv Normal Saline, Iv Immunoglobulin | 2026-11-10 |
| NCT02725060 | Autoimmune Basis for Postural Tachycardia Syndrome POTS, Other post-viral | Active Not Recruiting | Not applicable | Phenylephrine, Isoproterenol, 25 Micro-Ci Of Radiation | 2026-11-10 |
Browse all tracked trials: clinical trials tracker.
The same issue goes out by email on Substack. RSS and JSON Feed are available for readers and aggregators.
Subscribe on SubstackRSS feedJSON FeedIssues are regenerated from the live tracker data within their week and frozen afterwards; the snapshot behind this page is at data/2026-W47.json.